Jiudian Pharmaceutical: Special opinions of the board of directors on the assessment of the independence of independent directors
Board of Directors of Hunan Jiudian Pharmaceutical Co., Ltd.
Special opinions on the assessment of the independence of independent directors
The board of directors of Hunan Jiudian Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has verified the independence of the company's independent directors in accordance with the requirements of relevant laws, regulations and rules in accordance with the "Measures for the Administration of Independent Directors of Listed Companies", "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" and other relevant laws, regulations and rules. The details are as follows:
1. Self-examination of independence of independent directors
The company's board of directors received the "Independent Director Independence Self-Assessment Form" submitted by independent directors Ms. Yang Qiulin, Mr. Zhou Congshan, and Ms. Xiang Jing respectively on April 10, 2026. The above three independent directors of the company all confirmed that they do not have the circumstances that prohibit them from serving as independent directors as stipulated in Article 6 of the "Administrative Measures for Independent Directors of Listed Companies", that is, they do not belong to:
(1) Personnel working in the company or its affiliated enterprises and their spouses, parents, children, and major social relations;
(2) Directly or indirectly hold more than 1% of the company’s issued shares or are natural person shareholders and their spouses, parents, and children among the top ten shareholders of the company;
(3) Shareholders who directly or indirectly hold more than 5% of the company’s issued shares or persons who serve in the top five shareholders of the company and their spouses, parents, and children;
(4) Personnel working in affiliated enterprises of the company’s controlling shareholder or actual controller and their spouses, parents, and children;
(5) Persons who have significant business dealings with the company, its controlling shareholders, actual controllers or their respective subsidiaries, or persons who serve in units with significant business dealings, their controlling shareholders or actual controllers;
(6) Personnel who provide financial, legal, consulting, sponsorship and other services to the company and its controlling shareholders, actual controllers or their respective affiliated enterprises, including but not limited to all members of the project team of the intermediary agency providing services, reviewers at all levels, persons who signed the report, partners, directors, senior managers and principal persons in charge;
(7) Persons who have had the circumstances listed in the six items mentioned above in the past twelve months.
2. Special opinions of the board of directors on self-examination of independence of independent directors
According to the "Independent Director Independence Self-Assessment Form" submitted by the company's independent directors, Ms. Yang Qiulin, Mr. Zhou Congshan, and Ms. Xiang Jing respectively, it was verified by the company that: in addition to serving as independent directors of the company, the above-mentioned persons do not hold other positions, nor do they hold positions in the company's major shareholders. There is no interest relationship with the company and its major shareholders or other relationships that may affect independent and objective judgment.
In summary, the company's independent directors all comply with the relevant provisions on the independence of independent directors in the "Administrative Measures for Independent Directors of Listed Companies" and the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies".
Board of Directors of Hunan Jiudian Pharmaceutical Co., Ltd.
April 23, 2026